This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients.
Berkeley Group (Q1 update 5 September)
Full-year results from the firm saw Berkeley upgrade its targets for the coming years, but there was caution over the outlook for the key London market. We will get further detail on this at the first quarter (Q1) update, which will likely be key for share price direction. Strong forward sales and a well-maintained balance sheet do mean that the firm is well prepared for any downturn, something to bear in mind as the country heads towards key Brexit deadlines. At ten times forward earnings the shares are now priced in line with their five-year average, having been one standard deviation above it earlier in the year.
Berkeley’s shares have dropped back from their mid-year highs to the crucial £36.00 support zone. This has held since the middle of July, as it did in February and March. A break below this brings the July low of £35.00 into play. A recovery above £37.00 breaks the current narrow trading range, and would suggest a move back towards £39.08 in the near term.